Rapid measurement of drug release from temperature-sensitive liposomes by electron paramagnetic resonance and radioisotope techniques.
We have developed two new methods for quantifying drug release from temperature-sensitive liposomes. Large unilamellar vesicles were made by the reverse phase evaporation process. They contained a water-soluble electron paramagnetic resonance probe, trimethyl-4-amino-2,2,6,6-tetramethyl piperidine N-oxyl and the radioisotope cytosine-[3H]1-beta-D-arabinofuranoside in their aqueous compartment. Release of the electron paramagnetic resonance probe was measured by placing the liposomes in a solution of a spin label quenching agent, potassium ferricyanide, and monitoring the reduction in signal strength. The measurement of radioisotope released involved rapid ultracentrifugation of the liposomes after which the supernatant was tested for the presence of radioactivity. Both methods were found to be rapid and convenient ways of measuring drug release from temperature-sensitive liposomes and both methods gave comparable results. The radioisotope assay provides a direct measurement of drug leakage, whereas the electron spin resonance assay provides a continuous marker for liposome stability as a function of temperature.
D003561:Cytarabine / Q000008:administration & dosage; D004578:Electron Spin Resonance Spectroscopy; D007553:Isotope Labeling; D008081:Liposomes; D008854:Microscopy, Electron; D010539:Permeability; D004364:Pharmaceutical Preparations / Q000008:administration & dosage*; D013696:Temperature
D008081:Liposomes; D004364:Pharmaceutical Preparations; D003561:Cytarabine